US regulators on Friday tightened the distribution and prescription of Accutane to prevent the use of the acne treatment by pregnant women because it can cause birth defects.

Accutane is one of five drugs that David Graham, a safety researcher at the Food and Drug Administration, said should be subjected to closer scrutiny.